Ultragenyx Pharmaceutical reported $-79655000 in EBITDA for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -42.78M 23.1M
Acceleron Pharma XLRN:US $ -62.63M 0.05M
Agios Pharmaceuticals AGIO:US $ -88.87M 0.13M
Alexion Pharmaceuticals ALXN:US $ 892.3M 186.4M
Alnylam Pharmaceuticals ALNY:US $ -134.35M 39.3M
Aptinyx Inc APTX:US $ -19766000 5.89M
Biomarin Pharmaceutical BMRN:US $ 41.16M 14.24M
Bluebird Bio BLUE:US $ -234.8M 9.32M
Epizyme EPZM:US $ -55.92M 6.14M
Esperion Therapeutics ESPR:US $ -32380000 50.29M
Gw Pharmaceuticals GWPH:US $ -17.18M 2.02M
Insmed INSM:US $ -84649000 4.74M
IONIS PHARMACEUT IONS:US $ -68.34M 19.17M
Karyopharm Therapeutics KPTI:US $ -48819000 3.32M
Kyowa Hakko Kirin 4151:JP Y 19755M 131M
Macrogenics MGNX:US $ -37498000 11.07M
Mirati Therapeutics MRTX:US $ -163.78M 31.65M
Moderna Inc MRNA:US 3.13B 1.85B
Neurocrine Biosciences NBIX:US $ 70.4M 36.4M
Ptc Therapeutics PTCT:US $ -83.51M 1.05M
Puma Biotechnology PBYI:US $ -13.7M 36.8M
Regeneron Pharmaceuticals REGN:US $ 3418.3M 2238.2M
Sarepta Therapeutics SRPT:US $ -159.13M 26.19M
Ultragenyx Pharmaceutical RARE:US $ -79.66M 23.55M
Vertex Pharmaceuticals VRTX:US $ -5.12M 917.88M
Vital Therapies VTL:US $ -19.16M 13.22M
Xoma XOMA:US $ -3062000 3.36M